AMINOACYL TRANSFER RNA SYNTHETASES
    4.
    发明申请

    公开(公告)号:WO2022245902A2

    公开(公告)日:2022-11-24

    申请号:PCT/US2022/029775

    申请日:2022-05-18

    摘要: Aminoacyl-tRNA synthetase (aaRS) characteristics such as solubility and specificity are known to play key roles for individual applications, but it is not yet clear how best to evolve aaRS to address those needs. Thus, there is a need for aminoacyl-tRNA synthetases with improved characteristics. The invention provides aminoacyl-tRNA synthetases, compositions thereof, and methods for use thereof. Preferably, the invention features in vitro methods of producing a protein containing a noncanonical amino acid. Methods include contacting an in vitro translation system or contacting a cell with an expression vector with a Tyrosyl-tRNA Synthetase (TyrRS) polypeptide or a functional fragment thereof, comprising an alteration at an amino acid position Y37.

    T-CELL RECEPTOR SUBSTITUTIONS IN TRANSMEMBRANE DOMAIN

    公开(公告)号:WO2022099119A1

    公开(公告)日:2022-05-12

    申请号:PCT/US2021/058430

    申请日:2021-11-08

    发明人: MOCK, Jee Young

    摘要: The invention relates to fusion proteins comprising a transmembrane domain and an intracellular domain capable of providing a stimulatory signal or an inhibitory signal, and engineered T cell receptors comprising same. Specifically, the disclosure provides an engineered T Cell Receptor (TCR), comprising a first TCR subunit comprising a first transmembrane domain and a second TCR subunit comprising a second transmembrane domain, wherein the first transmembrane domain comprises a positively charged amino acid residue and the second transmembrane domain comprises a negatively charged amino acid residue, and wherein the interaction of the positively charged amino acid residue and the negatively charged amino acid residue specifically promote the formation of the engineered TCR receptor.